It is well known that germ-line and somatic pathogenic mutations in the tumor suppressor genes, BRCA1 and BRCA2 (BRCA1/2), confer increased risk for ovarian and breast cancers [15]. The gene discussed is BRCA1; the disease is breast carcinoma.